Therefore, the lower expression of RORA played a vital role in the invasiveness of GBMs via EIF4A3/CASC2/RORA feedback loop regulated TGF-β1/Smad signaling pathway might represent a promising therapeutic strategy for the treatment of GBM. This evidence concerns the gene CASC2 and glioblastoma.